To validate the relationship between miR-29a and PIK3CA in clinical settings, we examined data from the TCGA dataset and found that cervical cancer patients generally exhibited a higher expression of PIK3CA and lower expression of miR-29a. This evidence concerns the gene PIK3CA and cervical carcinoma.